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Introduction
============

Since its first description in 1967 \[[@B1]\], it has been accepted that acute respiratory distress syndrome (ARDS) includes a number of lung injuries of various origins whose consequences are decreased lung capacity available for ventilation, leading to the concept of \"baby lung\" \[[@B2]\]. Considerable progress has been made over the past decade in the ventilatory management of patients with ARDS. In particular, a strict limitation of tidal volume (V~T~) and plateau pressure (Pplat) below 30 cmH~2~O reduces mortality \[[@B3]\]. The application of positive end-expiratory pressure (PEEP) is recognized to recruit the lung and to restore functional residual capacity \[[@B4]\], but its optimum level is still widely debated \[[@B5]\].

The prone position (PP) may also be part of the ventilatory strategy. This method was proposed more than 30 years ago, initially in pathophysiological studies \[[@B6],[@B7]\]. Recently, Sud *et al*. \[[@B8]\] suggested, on the basis of pooled data from randomized, controlled trials, that PP may improve survival in the subgroup of patients with the most severe ARDS, that is, those with a ratio of partial pressure of arterial O~2~to fraction of inspired O~2~(PaO~2~/FiO~2~) \< 100 mmHg. Many questions remain unresolved. In particular, response to PP is usually defined according to changes in PaO~2~, with responders being those in whom the PaO~2~/FiO~2~ratio increases \> 20 mmHg after one to six hours in the PP \[[@B9]-[@B11]\]. However, we have previously reported that PP allows recruitment of a slow compartment previously excluded from ventilation \[[@B12]\]. This was associated with a decrease in partial pressure of arterial CO~2~(PaCO~2~), an indirect reflection of the reduction of the alveolar dead space (VD~alv~) \[[@B12]\]. Gattinoni *et al*. \[[@B10]\] also reported that the prognosis is improved in patients in whom PaCO~2~declines after an initial PP session. Finally, VD~alv~appears to be an independent risk factor for mortality in patients with ARDS \[[@B13]\]. In a recent study, Siddiki *et al*. \[[@B14]\] proposed evaluating the physiological dead space fraction (VD~physiol~/V~T~) by using a rearranged alveolar gas equation for PaCO~2~without any expired CO~2~measurement.

In this context, we conducted a prospective physiological study to evaluate the impact of PP on ventilatory mechanics, gas exchange and VD~alv~. Our main objective was to validate our hypothesis that changes in PaCO~2~and VD~alv~might be more relevant than changes in PaO~2~in defining the respiratory response to PP. Our second objective was to validate the method of evaluation of the VD~physiol~/V~T~proposed by Siddiki *et al*. \[[@B14]\].

Materials and methods
=====================

In our unit, patients with a PaO~2~/FiO~2~ratio \< 100 mmHg after 24 to 48 hours of mechanical ventilation are systematically turned to PP when hemodynamically stable \[[@B15]\]. Our study was approved by the Ethics Committee of the \"Société de Réanimation de Langue Française\" (SRLF-CE 07-213). After obtaining informed consent from the patients\' relatives, 15 patients were included in the study between January 2008 and March 2010. Inclusion criteria were (1) the presence of ARDS according to the definition of the Acute Respiratory Distress Syndrome Network \[[@B3]\]; (2) persistence of severe hypoxemia after 48 hours of mechanical ventilation, defined as a PaO~2~/FiO~2~ratio \< 100 mmHg; and (3) hemodynamic stability, defined as systolic blood pressure \> 90 mmHg with norepinephrine infusion at a rate \< 0.5 μg/kg/minute. Patients with chronic obstructive pulmonary disease were excluded.

All patients were ventilated in volume-controlled mode (Servo-i; Maquet SA, Ardon, France), sedated and paralyzed by infusion of atracurium. The heat and moisture exchanger was routinely removed and replaced by a heated humidifier to reduce instrumental dead space as previously reported \[[@B16]\]. The ventilator settings included a \"moderately restricted\" V~T~of 6 to 8 mL/kg measured body weight, a respiratory rate allowing us to limit hypercapnia without generating intrinsic PEEP and an inspiration/expiration ratio of 1:2 with an end inspiratory pause of 0.5 seconds. Pplat was strictly limited \< 30 cmH~2~O, and the PEEP selected was that which corrected the intrinsic PEEP, if any \[[@B17]\]. Ventilator settings were kept constant throughout the study. A recruitment maneuver was never used, and suction was not systematically performed. All patients were continuously monitored in terms of blood pressure with an arterial catheter, heart rate and O~2~saturation by pulse oximetry.

The study was conducted during the first session of PP. Our sessions routinely last 15 to 18 hours per day. Blood gas analysis, Pplat, total PEEP, end-tidal CO~2~(P~etCO2~) and mixed expired CO~2~(P~ECO2~) were recorded with the patient in the supine position, just before turning the patient to the PP, and every 3 hours in the PP until 15 hours had elapsed. Expired CO~2~was measured by a sensor positioned between the proximal end of the endotracheal tube and the Y piece of the ventilator circuit (COSMO; Novametrix, Wallingford, CT, USA). The ratio of VD/V~T~was calculated using the simplified Bohr equation \[[@B18]\] as follows: (1) VD~alv~/V~T~= 1 - P~etCO2~/PaCO~2~and (2) VD~physiol~/V~T~= 1 - P~ECO2~/PaCO~2~.

The estimated VD~physiol~/V~T~ratio was calculated as 1 - \[(0.86 × VCO~2est~)/(VE × PaCO~2~)\], where VCO~2est~is the estimated CO~2~production calculated using the Harris-Benedict equation \[[@B19]\] and VE is the expired minute ventilation.

Intrinsic PEEP was measured during a four-second end-expiratory occlusion period. Pplat was measured during a 0.5-second end-inspiratory pause. Respiratory system compliance (Crs) was calculated as Crs = V~T~/(Pplat - PEEP~total~). Responders to PP were defined in two different ways: (1) an increase in PaO~2~/FiO~2~ratio \> 20 mmHg after 15 hours of PP or (2) a decrease in PaCO~2~\> 2 mmHg after 15 hours of PP.

Statistical analysis
--------------------

Statistical analysis was performed using StatView 5 software (SAS Institute Inc., Cary, NC, USA). The continuous variables were expressed as medians (1st to 3rd interquartile range). Analysis of variance for repeated measurements was used for each parameter, and *P*\< 0.05 was considered statistically significant. Measured VD~physiol~/V~T~and estimated VD~physiol~/V~T~were compared according to Bland-Altman analysis, together with the concordance correlation coefficient in 78 paired data. The same method was used to compare variations of measured and estimated VD~physiol~/V~T~every three hours while the patient was in PP.

Results
=======

Two patients were excluded from the study because of a history of severe chronic obstructive pulmonary disease, which left a study population of 13 patients. The patients\' median age was 53 years (1st to 3rd interquartile range, 48 to 59 years), their median Simplified Acute Physiology Score II score was 62 (1st to 3rd interquartile range, 35 to 71) and their median Sequential Organ Failure Assessment score was 11 (1st to 3rd interquartile range, 8-13). All patients except one had ARDS of pulmonary origin. Eight patients had pneumonia, with six cases related to streptococcus pneumonia and two due to influenza (H1N1 virus). Two patients had aspiration, one had toxic shock syndrome and two had ARDS due to miscellaneous causes. No patient had abdominal hypertension or traumatic lung injury. Eleven patients required norepinephrine infusion. Respiratory parameters and blood gas analysis at the time of inclusion are reported in Table [1](#T1){ref-type="table"}.

###### 

Respiratory parameters and blood gas analysis at inclusion^a^

  Parameters                Median   1st to 3rd interquartile range
  ------------------------- -------- --------------------------------
  LIS                       3.25     3 to 3.25
  Tidal volume, mL/kg IDB   6.2      5.6 to 8.3
  RR, breaths/minute        22       18 to 26
  PEEP, cmH~2~O             6        5 to 7
  FiO~2~, %                 90       90 to 100
  Pplat, cmH~2~O            27       26 to 28
  PaO~2~/FiO~2~, mmHg       70       51 to 77
  PaCO~2~, mmHg             58       52 to 60
  Crs, mL/cmH~2~O           16       13 to 30
  VD~alv~/V~T~              0.42     0.35 to 0.47
  VD~alv~, mL               159      95 to 236

^a^Crs: compliance of the respiratory system; IDB: ideal body weight; LIS: lung injury score \[[@B32]\]; PaCO~2~: partial pressure of arterial CO~2~; PaO~2~/FiO~2~: ratio of partial pressure of arterial O~2~to fraction of inspired O~2~; PEEP: positive end-expiratory pressure; Pplat: plateau pressure; RR: respiratory rate; VD~alv~/V~T~: ratio of alveolar dead space to tidal volume.

A significant increase in PaO~2~/FiO~2~ratio occurred after 15 hours of PP, from 70 mmHg (51 to 77) in the supine position to 99 mmHg in the prone (83 to 139) (*P*\< 0.0001) (Table [2](#T2){ref-type="table"}). A significant decrease in PaCO~2~was also observed, from 58 mmHg (52 to 60) to 52 mmHg (47 to 56) (*P*= 0.04) (Table [2](#T2){ref-type="table"}), with the lowest value occurring after nine hours of PP. As noted in Table [2](#T2){ref-type="table"}, Pplat was significantly reduced (*P*= 0.0004) and Crs improved (from 16 mL/cmH~2~O (13 to 30) to 18 mL/cmH~2~O (15 to 30); *P*= 0.02). Finally, the VD~alv~/V~T~ratio was significantly reduced from 0.42 (0.35 to 0.47) to 0.40 (0.26 to 0.45), with the lowest value occurring after three hours in PP (hour 3) (0.31) (Table [2](#T2){ref-type="table"}).

###### 

Changes in respiratory mechanics, blood gas analysis and VD~alv~in PP

  Parameters            Supine                PP H3                 PP H6                 PP H9                 PP H12                PP H15                *P*value
  --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- -----------
  PaO~2~/FiO~2~, mmHg   70 (51 to 77)         91 (81 to 103)        87 (73 to 139)        90 (81 to 111)        93 (83 to 137)        99 (83 to 139)        \< 0.0001
  PaCO~2~, mmHg         58 (52 to 60)         54 (51 to 58)         54 (45 to 59)         50 (47 to 59)         54 (47 to 56)         52 (47 to 56)         0.04
  Pplat, cmH~2~O        27 (26 to 28)         25 (23 to 27)         25 (22 to 26)         25 (23 to 26)         25 (21 to 26)         25 (24 to 26)         0.0004
  Crs, mL/cmH~2~O       16 (13 to 30)         18 (14 to 36)         17 (15 to 40)         18 (15 to 38)         19 (15 to 38)         18 (15 to 30)         0.02
  VD~alv~/V~T~          0.42 (0.35 to 0.47)   0.31 (0.28 to 0.41)   0.35 (0.22 to 0.39)   0.35 (0.26 to 0.39)   0.39 (0.28 to 0.44)   0.40 (0.26 to 0.45)   0.007

^a^Crs: compliance of the respiratory system; PP: prone position, Pplat: plateau pressure, VD~alv~/V~T~: ratio of alveolar dead space to tidal volume. H3, H6, H9, H12 and H15: 3, 6, 9, 12 and 15 hours of PP, respectively. *P*value is between supine position and PP. Data are expressed as medians (1^st^to 3^rd^interquartile range).

Seven patients were classified as \"PaO~2~responders\" and six were classified as \"PaO~2~nonresponders\" according to PaO~2~/FiO~2~ratio changes. No differences in VD~alv~/V~T~ratios or PaCO~2~or Pplat alterations during PP were observed between groups (Table [3](#T3){ref-type="table"} and Figure [1](#F1){ref-type="fig"}), whereas Crs increased more in the responders (Table [3](#T3){ref-type="table"}). Seven patients were also classified as \"PaCO~2~responders\" and six as \"PaCO~2~nonresponders\" according to the PaCO~2~changes. However, when compared with the PaO~2~/FiO~2~classification, four patients were classified differently. As shown in Table [4](#T4){ref-type="table"} and Figure [2](#F2){ref-type="fig"}, VD~alv~/V~T~, PaO~2~/FiO~2~, PaCO~2~, Pplat and Crs were significantly more altered in responders than in nonresponders. As shown in Figure [3](#F3){ref-type="fig"}, we found no correlation between changes in VD~alv~/V~T~and changes in PaO~2~/FiO~2~(*P*= 0.95), whereas we found a negative correlation between changes in VD~alv~/V~T~and changes in Crs (*r*= 0.29, *P*= 0.03).

###### 

Changes in respiratory mechanics, blood gas analysis and VD~alv~in PaO~2~responders (*n*= 7) and PaO~2~nonresponders (*n*= 6)^**a**^

                             Supine       PP H3                                PP H6        PP H9                                PP H12       PP H15                                                                                                                                                                                     
  --------------------- ---- ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ --------------
  **Parameters**             **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   ***P*value**
                                                                                                                                                                                                                                                                                                                                         
  PaO~2~/FiO~2~, mmHg   R    51           (48 to 69)                           91           (86 to 112)                          94           (83 to 142)                          97           (86 to 126)                          98           (93 to 142)                          108          (99 to 142)                          0.0003
                        NR   77           (76 to 81)                           91           (82 to 99)                           79           (73 to 88)                           84           (82 to 99)                           84           (82 to 87)                           89           (82 to 97)                           
  VD~alv~/V~T~          R    0.43         (0.41 to 0.47)                       0.35         (0.31 to 0.46)                       0.35         (0.29 to 0.41)                       0.38         (0.23 to 0.42)                       0.40         (0.31 to 0.40)                       0.41         (0.32 to 0.45)                       0.31
                        NR   0.42         (0.36 to 0.50)                       0.35         (0.28 to 0.47)                       0.31         (0.22 to 0.43)                       0.32         (0.27 to 0.44)                       0.36         (0.28 to 0.51)                       0.35         (0.27 to 0.53)                       
  PaCO~2~, mmHg         R    58           (54 to 60)                           52           (51 to 58)                           51           (47 to 57)                           49           (48 to 53)                           54           (48 to 55)                           51           (47 to 55)                           0.14
                        NR   55           (52 to 60)                           56           (51 to 62)                           57           (48 to 62)                           55           (48 to 60)                           54           (48 to 63)                           53           (48 to 58)                           
  Pplat, cmH~2~O        R    27           (27 to 30)                           25           (22 to 26)                           24           (23 to 26)                           24           (23 to 26)                           24           (22 to 26)                           24           (24 to 25)                           0.27
                        NR   27           (24 to 28)                           25           (24 to 28)                           25           (22 to 26)                           25           (23 to 27)                           26           (22 to 26)                           26           (25 to 26)                           
  Crs, mL/cmH~2~O       R    16           (13 to 28)                           19           (16 to 37)                           18           (16 to 38)                           18           (16 to 35)                           20           (17 to 35)                           19           (17 to 33)                           0.023
                        NR   19           (14 to 31)                           21           (14 to 33)                           21           (14 to 36)                           21           (14 to 34)                           19           (15 to 34)                           19           (15 to 34)                           

^a^Crs: compliance of the respiratory system; NR: nonresponders; PP: prone position; Pplat: plateau pressure; R: responders; VD~alv~/V~T~: ratio of alveolar dead space to tidal volume. *P*values represent comparison of changes between responders and nonresponders. H3, H6, H9, H12 and H15: 3, 6, 9, 12 and 15 hours of PP, respectively. Responders are defined as patients whose PaO~2~/FiO~2~increased \> 20 mmHg after 15 hours of PP.

![**Alterations during PP in PaO~2~/FiO~2~, PaCO~2~, plateau pressure (Pplat) and alveolar dead space (VD~alv~/V~T~) in responders (solid lines) and nonresponders (dotted lines) according to PaO~2~/FiO~2~changes**. \"PaO~2~responders\" were defined by an increase in PaO~2~/FiO~2~\> 20 mmHg after 15 hours of PP (PP H15). Shown are box and whisker plots. Median = horizontal line inside the box; upper and lower quartiles = whisker plot. Boxes and triangles represent values higher or lower than the upper or lower quartiles. \**P*\< 0.05 for comparison of changes in responders versus nonresponders. PP: prone position.](cc10324-1){#F1}

###### 

Changes in respiratory mechanics, blood gas analysis and VD~alv~in PaCO~2~responders (*n*= 7) and PaCO~2~nonresponders (*n*= 6)^**a**^

                             Supine       PP H3                                PP H6        PP H9                                PP H12       PP H15                                                                                                                                                                                     
  --------------------- ---- ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ------------ ------------------------------------ ---------------
  **Parameters**             **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   **Median**   **1st to 3rd interquartile range**   ***P*values**
                                                                                                                                                                                                                                                                                                                                         
  PaCO~2~, mmHg)        R    58           (55 to 59)                           57           (51 to 57)                           54           (44 to 57)                           50           (46 to 53)                           50           (46 to 55)                           50           (47 to 52)                           0.005
                        NR   56           (49 to 60)                           52           (49 to 60)                           54           (49 to 62)                           54           (49 to 60)                           56           (51 to 62)                           57           (49 to 59)                           
  VD~alv~/V~T~          R    0.40         (0.37 to 0.45)                       0.31         (0.29 to 0.46)                       0.23         (0.31 to 0.40)                       0.26         (0.26 to 0.42)                       0.28         (0.24 to 0.44)                       0.28         (0.23 to 0.43)                       0.005
                        NR   0.45         (0.42 to 0.51)                       0.38         (0.32 to 0.47)                       0.38         (0.35 to 0.43)                       0.37         (0.33 to 0.45)                       0.42         (0.39 to 0.51)                       0.44         (0.39 to 0.54)                       
  PaO~2~/FiO~2~, mmHg   R    70           (59 to 78)                           103          (96 to 136)                          138          (83 to 146)                          111          (91 to 156)                          136          (95 to 142)                          139          (103 to 148)                         0.0001
                        NR   63           (44 to 76)                           83           (80 to 89)                           79           (73 to 88)                           83           (74 to 88)                           84           (62 to 87)                           89           (70 to 97)                           
  Pplat, cmH~2~O        R    27           (24 to 27)                           23           (22 to 25)                           23           (20 to 25)                           23           (22 to 25)                           21           (21 to 25)                           23           (21 to 25)                           0.002
                        NR   28           (26 to 28)                           26           (24 to 28)                           26           (25 to 28)                           26           (25 to 28)                           26           (25 to 26)                           26           (25 to 26)                           
  Crs, mL/cmH~2~O       R    28           (15 to 30)                           30           (18 to 36)                           34           (17 to 41)                           32           (18 to 38)                           32           (19 to 39)                           31           (18 to 39)                           0.002
                        NR   15           (12 to 20)                           15           (13 to 24)                           15           (13 to 23)                           15           (13 to 23)                           15           (14 to 22)                           15           (14 to 22)                           

^a^Crs: compliance of the respiratory system; NR: nonresponders; PP: prone position; Pplat: plateau pressure; R: responders; VD~alv~/V~T~: ratio of alveolar dead space to tidal volume. *P*value represents comparison of changes between responders and nonresponders. H3, H6, H9, H12 and H15: 3, 6, 9, 12 and 15 hours of PP, respectively. Responders are defined as patients whose PaCO~2~decreased \> 2 mmHg after 15 hours of PP.

![**Alterations during PP in PaO~2~/FiO~2~, PaCO~2~, plateau pressure (Pplat) and alveolar dead space (VD~alv~/V~T~) in responders (solid lines) and nonresponders (dotted lines) according to PaCO~2~changes**. \"PaCO~2~responders\" were defined by a decrease in PaCO~2~\> 2 mmHg after 15 hours of PP (PP H15). Shown are box and whisker plots. Median = horizontal line inside the box; upper and lower quartiles = whisker plot. Boxes and triangles represent values higher or lower than the upper or lower quartiles. \**P*\< 0.05 for comparison of changes in responders versus nonresponders. PP: prone position.](cc10324-2){#F2}

![**Correlation between changes in alveolar dead space (ΔVD~alv~/V~T~) and changes in compliance of the respiratory system (ΔCrs, left) or in PaO~2~/FiO~2~(ΔPaO~2~/FiO~2~, right) at each time of the study when compared with the supine position**.](cc10324-3){#F3}

As shown in Figure [4](#F4){ref-type="fig"}, estimated VD~physiol~/V~T~systematically underestimated measured VD~physiol~/V~T~, with a poor concordance correlation coefficient of 0.19 (95% confidence interval (95% CI) 0.091 to 0.28), a bias of 0.16 and an agreement between -0.05 and 0.37. Concerning changes in VD~physiol~/V~T~during PP, estimated VD~physiol~/V~T~had a concordance correlation coefficient of 0.51 (95% CI 0.32 to 0.66) (Figure [4](#F4){ref-type="fig"}).

![**Comparison between measured VD~physiol~/V~T~and estimated VD~physiol~/V~T~**\[[@B14]\]**using a Bland and Altman representation (left) and a linear correlation (right)**. **(A)**and **(B)**Comparison for each paired data set (*n*= 78) in the supine position and after 3, 6, 9, 12 and 15 hours in the prone position. **(C)**and **(D)**Comparison of changes in VD~physiol~/V~T~assessed according to the two methods between each time of measurement and the previous one. VD~physiol~/V~T~: ratio of physiological dead space to tidal volume.](cc10324-4){#F4}

Discussion
==========

One of the objectives of our study was to describe alterations in VD~alv~induced by PP. ARDS is characterized by a heterogeneous lung with the existence of a slow compartment \[[@B18],[@B20]\], defined as areas available for, but partially or totally excluded from, ventilation due in part to a bronchiolar collapse \[[@B12],[@B21]\]. In a previous study, we reported that PP may induce recruitment of this slow compartment, as suggested by its ability to counteract intrinsic PEEP and to decrease the expiratory time constant \[[@B12]\]. In the same study, we also reported that PP leads to a decrease in PaCO~2~, suggesting diminution of VD~alv~(alveolar dead space) \[[@B12]\]. Our present study demonstrates that PP may induce a decrease in VD~alv~. It occurred from the third hour and was maintained throughout the PP session. VD~alv~may be the consequence of nonperfused or poorly perfused lung areas in ventilated anterior areas, but also of a slow compartment partially excluded from ventilation. Our results suggest that PP induces functional lung recruitment, especially since decreases in VD~alv~related to PP were associated with a decrease in Pplat and strongly correlated with improvement in compliance. Interestingly, in a previous study of 16 ARDS patients, Pelosi *et al*. \[[@B22]\] did not find a decrease in VD~physiol~after 120 minutes in PP. One of the explanations for this discrepancy could be the different levels of PEEP in the two studies: 12.3 cmH~2~O in Pelosi *et al*.\'s study and only 6 cmH~2~O in our study. However, Protti *et al*. \[[@B23]\], in a study of patients ventilated with a PEEP of 13 cmH~2~O, demonstrated a strong relation between lung recruitability and decreased PaCO~2~related to PP. Pelosi *et al*. also did not report a decrease in Pplat in PP, as we found, but after returning patients to the supine position \[[@B22]\]. This could be explained by the fact that they used roll under the upper part of the chest wall, leading to a significant impairment in chest wall compliance \[[@B22]\], whereas we did not.

The most beneficial reported effect of PP is oxygenation improvement \[[@B24],[@B25]\]. However, this better oxygenation can be due to (1) lung recruitment related to restoration of functional residual capacity \[[@B7]\] and improvement of the diaphragmatic movement in the posterior part \[[@B26]-[@B28]\] or (2) simply to an improvement in the ventilation/perfusion ratio due to a decreased hydrostatic gradient between the anterior and posterior parts of the lung \[[@B26],[@B29]\]. Whereas the first mechanism is crucial, one can say that the second mechanism is less important. This is why the second objective of our study was to test whether the response to PP in terms of PaCO~2~was physiologically more relevant than in terms of PaO~2~/FiO~2~ratio. Gattinoni *et al*. \[[@B10]\] reported that an increase in PaO~2~/FiO~2~ratio \> 20 mmHg after six hours of PP is not predictive of the patient\'s prognosis, whereas a decline in PaCO~2~≥1 mmHg is. In our present study, 7 of 13 patients were PaO~2~responders (increased PaO~2~/FiO~2~ratio \> 20 mmHg after 15 hours of PP). However, changes in Pplat, PaCO~2~and VD~alv~did not differ between PaO~2~responders and PaO~2~nonresponders. On the other hand, 7 of 13 patients were PaCO~2~responders (decreased PaCO~2~\> 2 mmHg after 15 hours of PP). PaCO~2~responders had a significant decrease in Pplat and VD~alv~, as well as a significant increase in oxygenation and compliance, compared with nonresponders. Our results are in accordance with a recent study of 32 ARDS patients \[[@B23]\], in which the investigators reported that PaCO~2~variation induced by PP, and not PaO~2~/FiO~2~variation, is associated with lung recruitability. Interestingly, in our study, changes in VD~alv~were not correlated with changes in oxygenation but were strongly correlated with changes in compliance of the respiratory system.

An unexpected result of our work concerns the change over time of respiratory mechanics, blood gas analysis and VD~alv~. For many years, our PP protocol has been to turn patients to PP for up to 15 to 18 hours per day for 3 days \[[@B15]\]. In the study by Mancebo *et al*. \[[@B30]\], which concluded that PP may reduce mortality in patients with severe ARDS, PP sessions lasted 20 hours/day. In a recent study, we demonstrated that PP sessions that lasted 18 hours/day were independently associated with survival \[[@B31]\]. In the present study, the maximum effect of PP for VD~alv~, PaCO~2~and Pplat occurred six to nine hours after turning patients to PP. Later the effect seemed to be a decline. How this affects the effect of PP on patient prognosis remains to be elucidated.

The second objective of our study was to validate a recently proposed method to evaluate the VD~physiol~/V~T~ratio \[[@B14]\]. The method is based on CO~2~production calculated from the Harris-Benedict equation \[[@B19]\] and on the expired minute ventilation. Siddiki *et al*. \[[@B14]\] reported that it was associated with mortality in acute lung injury patients in a dose-response manner and proposed its routine use to estimate VD~physiol~/V~T~. However, they did not report any comparison with measured VD~physiol~/V~T~. In the present study, we have demonstrated that this method significantly underestimates VD~physiol~/V~T~, rendering it not accurate enough to assess the degree of lung injury. Interestingly, changes in estimated VD~physiol~/V~T~during PP appeared better correlated with changes in measured VD~physiol~/V~T~and could be proposed in the future in this field. Siddiki *et al*. \[[@B14]\] proposed the method in the context of a much larger series than ours and in patients with less severe ARDS, rendering it difficult to draw any definitive conclusions.

Our work is limited by the small number of patients included. This is a consequence of our routine protocol, which strictly restricts PP to patients with the most severe ARDS, that is, those with a PaO~2~/FiO~2~ratio \< 100 mmHg after 48 hours of ventilation. This also explains why it is not possible to link our results to outcomes. However, despite this limitation, we consider our results relevant from a physiological point of view.

Conclusions
===========

In conclusion, our study demonstrates that PP induces a decrease in PaCO~2~and VD~alv~. This is related to an improvement in respiratory mechanics, with a decrease in Pplat and an increase in compliance. Testing the response to PP appeared to be physiologically more relevant using PaCO~2~changes than PaO~2~/FiO~2~changes. How this may affect management at the bedside remains to be studied. Estimated VD~physiol~/V~T~ratios systematically underestimated measured VD~physiol~/V~T~ratios.

Key messages
============

• PP induced a decrease in VD~alv~/V~T~, which was correlated with an improvement in respiratory mechanics.

• Defining the respiratory response to PP appeared more relevant when using PaCO~2~changes rather than PaO~2~/FiO~2~changes.

• Estimated VD~physiol~/V~T~using the Harris-Benedict equation systematically underestimated measured VD~physiol~/V~T~.

Abbreviations
=============

ARDS: acute respiratory distress syndrome; P~ECO2~: mixed expired PCO~2~; PEEP: positive end-expiratory pressure; P~etCO2~: end-tidal PCO~2~; PP: prone position; Pplat: plateau pressure; VD~alv~: alveolar dead space; VD~physiol~: physiological dead space.
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